ValueAct Holdings, L.P., Director Other at Valeant Pharmaceuticals International, Inc. (VRX), bought 3,000,000 shares at $10.88 ($32.5M) on 2017-03-14, disclosed to the SEC on 2017-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.81 | 2,500,000 | $27.0M | 83.2% |
| 2 | $10.88 | 500,000 | $5.4M | 16.8% |
| Total | $10.82 avg | 3,000,000 | $32.5M | 100% |
| Filing → |
| CBRE | SELL | 2021-08-12 | $96.1M | — | Filing → |
| STX | SELL | 2020-12-31 | $173.1M | — | Filing → |
| AES | BUY | 2019-08-14 | $3.0M | — | Filing → |